Cardiovascular GLP-1 indication approval 2026: Wegovy (semaglutide)
52%YES chance
Yes
52%
No
48%
Now 51.8%
Resolution
Resolves to the first GLP-1 to win an additional cardiovascular indication from FDA in 2026.
Source: https://www.fda.gov/
Resolves by Apr 8, 2027.
Recent trades
- YES@drewhayes15.6 sh@ 52%8 SP
- YES@wrenvargas9.9 sh@ 51%5 SP
- YES@wrenvargas9.9 sh@ 51%5 SP
- 10 sh@ 50%5 SP
- 10 sh@ 50%5 SP
- 10.1 sh@ 50%5 SP
- YES@rowanmonroe9.9 sh@ 51%5 SP
- YES@lanepowell10 sh@ 50%5 SP
- 10 sh@ 50%5 SP
Top holders
YES holders
No holders yet.
NO holders
No holders yet.
News
Refreshed every 6 hours
No news yet. Endcap's news crawler refreshes every 6 hours.